These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 8171003)

  • 61. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
    Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
    Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir.
    Lin X; Irwin D; Kanazawa S; Huang L; Romeo J; Yen TS; Peterlin BM
    J Virol; 2003 Aug; 77(15):8227-36. PubMed ID: 12857891
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.
    Williams SA; Kwon H; Chen LF; Greene WC
    J Virol; 2007 Jun; 81(11):6043-56. PubMed ID: 17376917
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency.
    Emiliani S; Van Lint C; Fischle W; Paras P; Ott M; Brady J; Verdin E
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6377-81. PubMed ID: 8692823
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.
    Woffendin C; Ranga U; Yang Z; Xu L; Nabel GJ
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2889-94. PubMed ID: 8610137
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
    Kashanchi F; Sadaie MR; Brady JN
    Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Derivation of a biologically contained replication system for human immunodeficiency virus type 1.
    Chen H; Boyle TJ; Malim MH; Cullen BR; Lyerly HK
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7678-82. PubMed ID: 1502183
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency.
    Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L
    mBio; 2018 Nov; 9(6):. PubMed ID: 30401776
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The blocks to human immunodeficiency virus type 1 Tat and Rev functions in mouse cell lines are independent.
    Winslow BJ; Trono D
    J Virol; 1993 Apr; 67(4):2349-54. PubMed ID: 8445733
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1.
    Li CJ; Wang C; Friedman DJ; Pardee AB
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5461-4. PubMed ID: 7777531
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The regulation of human immunodeficiency virus type-1 gene expression.
    Kingsman SM; Kingsman AJ
    Eur J Biochem; 1996 Sep; 240(3):491-507. PubMed ID: 8856047
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Compatibility of Tat and Rev transactivators in the primate lentiviruses.
    Sakai H; Sakuragi J; Sakuragi S; Kawamura M; Adachi A
    Arch Virol; 1993; 129(1-4):1-10. PubMed ID: 8385908
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2.
    Cannon P; Kim SH; Ulich C; Kim S
    J Virol; 1994 Mar; 68(3):1993-7. PubMed ID: 8107261
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activation.
    Klichko V; Archin N; Kaur R; Lehrman G; Margolis D
    J Virol; 2006 May; 80(9):4570-9. PubMed ID: 16611917
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus.
    Dayton AI; Terwilliger EF; Potz J; Kowalski M; Sodroski JG; Haseltine WA
    J Acquir Immune Defic Syndr (1988); 1988; 1(5):441-52. PubMed ID: 2851651
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Molecular biology of the human immunodeficiency virus type 1.
    Haseltine WA
    FASEB J; 1991 Jul; 5(10):2349-60. PubMed ID: 1829694
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro.
    Hsu MC; Dhingra U; Earley JV; Holly M; Keith D; Nalin CM; Richou AR; Schutt AD; Tam SY; Potash MJ
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6395-9. PubMed ID: 8341644
    [TBL] [Abstract][Full Text] [Related]  

  • 78. RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat.
    Pendergrast PS; Hernandez N
    J Virol; 1997 Feb; 71(2):910-7. PubMed ID: 8995607
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals.
    Furtado MR; Kingsley LA; Wolinsky SM
    J Virol; 1995 Apr; 69(4):2092-2100. PubMed ID: 7884855
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rev-induced modulation of Nef protein underlies temporal regulation of human immunodeficiency virus replication.
    Ahmad N; Maitra RK; Venkatesan S
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6111-5. PubMed ID: 2788283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.